iSpecimen Inc. (ISPC)

↓ Download CSV

CIK 0001558569 · Nasdaq · Services-Commercial Physical & Biological Research

  • Sector Services
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, iSpecimen Inc. reported revenue of $1.93M, down 79.2% from the prior year. The company ran a net loss, with a net margin of -543.7%. It held $9.53M in total assets against $6.44M in total liabilities.

Key ratios (FY2025)

-465.4%
Operating margin
-543.7%
Net margin
-339.6%
Return on equity
-79.2%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019
Revenue$1.93M$9.29M$9.93M
Cost of Revenue$1.90M$5.30M$4.82M$4.76M$5.25M$3.59M
Operating Income-$8.98M-$12.73M-$11.17M-$10.19M-$5.93M-$2.41M
Net Income-$10.49M-$12.50M-$11.10M-$10.25M-$8.96M-$4.65M
EPS (Diluted)$-2.28$-17.58$-24.55$-1.16$-2.09$-4.97
Total Assets$9.53M$9.35M$15.82M$24.62M$35.72M$6.21M
Total Liabilities$6.44M$6.04M$6.08M$4.31M$5.93M$22.31M
Shareholders' Equity$3.09M$3.31M$9.74M$20.31M$29.79M-$27.28M-$22.72M
Cash & Equivalents$6.88M$1.88M$2.34M$15.31M$27.74M$695.9K
Operating Cash Flow-$4.24M-$8.26M-$5.81M-$5.82M-$10.67M-$288.4K
Capital Expenditures$454$31.5K$19.5K$215.5K$2.5K$426
Shares Outstanding8.48M1.70M454.2K8.93M8.73M936.2K